SEOM-GEICO clinical guideline on epithelial ovarian cancer (2023).
Clin Transl Oncol
; 2024 Jul 15.
Article
in En
| MEDLINE
| ID: mdl-39008159
ABSTRACT
In recent years, the incorporation of new strategies to the therapeutic armamentarium has completely changed the outcomes of epithelial ovarian cancer (EOC). The identification of new predictive and prognostic biomarkers has also enabled the selection of those patients more likely to respond to targeted agents. Nevertheless, EOC is still a highly lethal disease and resistance to many of these new agents is common. The objective of this guideline is to summarize the most relevant strategies to manage EOC, to help the clinician throughout the challenging diagnostic and therapeutic processes and to provide evidence-based recommendations.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Clin Transl Oncol
Year:
2024
Document type:
Article
Affiliation country:
Spain
Country of publication:
Italy